Vaxess Technologies

About:

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Website: http://www.vaxess.com

Twitter/X: vaxess

Top Investors: Mission BioCapital, Verizon, RA Capital Management, National Science Foundation, National Institutes of Health

Description:

Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low resource settings.